FDA launches pilot program for enhanced system to track and trace drugs

Members of the pharmaceutical distribution supply chain, including dispensers such as hospitals and pharmacies, can apply through March 11 to participate in a Food and Drug Administration pilot program that will inform the development of an enhanced electronic, interoperable track-and-trace system to take effect in 2023 under the Drug Supply Chain Security Act of 2013. FDA said the program will aid in identifying attributes the system will need for enhanced product tracing and verification, as well as electronic means to share the information. For more information, visit www.fda.gov.